Matches in Wikidata for { <http://www.wikidata.org/entity/Q102140332> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- Q102140332 description "2020 ވަނަ އަހަރުގެ ނޮވެމްބަރުމަހުގެ 17ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ސައިންޓިފިކް ލިޔުމެއް" @default.
- Q102140332 description "artículu científicu espublizáu en payares de 2020" @default.
- Q102140332 description "scientific article published on 17 November 2020" @default.
- Q102140332 description "wetenschappelijk artikel" @default.
- Q102140332 description "наукова стаття, опублікована 17 листопада 2020" @default.
- Q102140332 name "Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience" @default.
- Q102140332 name "Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience" @default.
- Q102140332 name "Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience" @default.
- Q102140332 type Item @default.
- Q102140332 label "Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience" @default.
- Q102140332 label "Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience" @default.
- Q102140332 label "Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience" @default.
- Q102140332 prefLabel "Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience" @default.
- Q102140332 prefLabel "Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience" @default.
- Q102140332 prefLabel "Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience" @default.
- Q102140332 P1433 Q102140332-98169FAC-0973-41C8-9F68-86ADDEDC698C @default.
- Q102140332 P1476 Q102140332-56D92318-DDC1-4525-AE7E-2D2872183248 @default.
- Q102140332 P2093 Q102140332-387F4CAD-75A7-4AF8-AE56-0D72705E2AD4 @default.
- Q102140332 P2093 Q102140332-4232365F-9D34-4FBF-80F3-B1536566D649 @default.
- Q102140332 P2093 Q102140332-62DB6E8E-1DAA-4990-B9B6-EE57245CB017 @default.
- Q102140332 P2093 Q102140332-6540A992-1C1C-49CD-8AF1-DAB7EA4D5C04 @default.
- Q102140332 P2093 Q102140332-81226F66-5C0E-435C-8657-8CE50A4E9E97 @default.
- Q102140332 P2093 Q102140332-861D1066-C75F-40D0-A469-B9D84C95AF6F @default.
- Q102140332 P2093 Q102140332-8C10C6C3-FA47-408A-AF64-E2258449EB47 @default.
- Q102140332 P2093 Q102140332-8FE500BD-FDF4-4E1B-AE27-C382171E84D9 @default.
- Q102140332 P2093 Q102140332-D2707A89-C0A6-40DB-9733-C2789BFD8844 @default.
- Q102140332 P2093 Q102140332-D28D08D1-FF5A-4C9D-A49D-369AB9698802 @default.
- Q102140332 P2093 Q102140332-F64591C1-C406-436C-A7D8-9B132102C457 @default.
- Q102140332 P304 Q102140332-21FD180C-5120-4219-8414-6BDCCA1FC99F @default.
- Q102140332 P31 Q102140332-8330C23E-7370-4EAE-88D3-CBAABBBB0DCC @default.
- Q102140332 P356 Q102140332-3FE46813-FE1C-419C-9CA1-1013B420A429 @default.
- Q102140332 P433 Q102140332-F13A9240-79C1-49F4-9FE9-E0AF35DDDFBA @default.
- Q102140332 P478 Q102140332-9DD86856-B662-4C48-B46E-754B42E8842A @default.
- Q102140332 P50 Q102140332-086BD4A0-D6DF-4F77-BF75-EA4FBDED3A00 @default.
- Q102140332 P577 Q102140332-E739F1B5-455B-4203-8444-BB79AB4D5B76 @default.
- Q102140332 P698 Q102140332-CAFC5A92-2AFC-46C7-8ED2-C4CA6F46DA8A @default.
- Q102140332 P921 Q102140332-3C15C4DE-67D2-4E8A-9A06-702CD80CAD85 @default.
- Q102140332 P921 Q102140332-CC1F6407-EA1A-4961-976B-FCF48625F4D4 @default.
- Q102140332 P921 Q102140332-E560FC08-80D0-4AC7-A16F-8406A9B8D0F5 @default.
- Q102140332 P356 S13063-020-04862-6 @default.
- Q102140332 P698 33203469 @default.
- Q102140332 P1433 Q7840023 @default.
- Q102140332 P1476 "Clinical trials with cannabis medicines-guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience" @default.
- Q102140332 P2093 "Anna Walsh" @default.
- Q102140332 P2093 "Courtney Hill" @default.
- Q102140332 P2093 "Daryl Efron" @default.
- Q102140332 P2093 "Helen Irving" @default.
- Q102140332 P2093 "Judith Lacey" @default.
- Q102140332 P2093 "Julie Hanson" @default.
- Q102140332 P2093 "Kaitlyn Taylor" @default.
- Q102140332 P2093 "Meera Agar" @default.
- Q102140332 P2093 "Michael Kennedy" @default.
- Q102140332 P2093 "Paul Lightfoot" @default.
- Q102140332 P2093 "Rachel Galettis" @default.
- Q102140332 P304 "932" @default.
- Q102140332 P31 Q13442814 @default.
- Q102140332 P356 "10.1186/S13063-020-04862-6" @default.
- Q102140332 P433 "1" @default.
- Q102140332 P478 "21" @default.
- Q102140332 P50 Q44551189 @default.
- Q102140332 P577 "2020-11-17T00:00:00Z" @default.
- Q102140332 P698 "33203469" @default.
- Q102140332 P921 Q1132684 @default.
- Q102140332 P921 Q237151 @default.
- Q102140332 P921 Q59057226 @default.